Provider
QP66-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Noctiva (desmopressin acetate)
Program effective Date: Aug 21, 2018
Search Results
Displaying 2901 - 2910 of 3701 results
Provider
QP16-17 Contract Renewal Overlapping with Termination Notices for Interpreter Agencies
Program effective Date: Jul 20, 2017
Provider
QP20-17 Searching Eligibility and Benefits
Program effective Date: Aug 08, 2017
Provider
QP67-18 Pharmacy Benefit Exclusion for Alferon N (interferon alpha-n3), Cytovene (ganciclovir), Foscarvir (foscarnet), Prevymis (letermovir), Trogarzo (ibalizu,ab-uiyk), Vistide (cidofovir) and Zovirax (actclovir)
Program effective Date: Aug 21, 2018
Provider
QP72-18 Pharmacy Benefit Update - New Drug-Related Step Therapy with Quantity Limit Criteria: Dipeptidyl Peptidase - 4 (DPP-4) Inhibitors
Program effective Date: Aug 21, 2018
Provider
QP28-17 Notification of Provider Submitted Appeals
Program effective Date: Sep 12, 2017
Provider
QP82-18 Pharmacy Benefit Exclusion for Azedra (iobenguane I 131) Intravenous Injection
Program effective Date: Sep 28, 2018
Provider
QP86-18 Addition of Drug to the Calcitonin Gene-Related Peptide (CGRP) Prior Authorization with Quantity Limit Program
Program effective Date: Nov 14, 2018
Provider
QP35-17 Implementation of New Utilization Management Platform
Program effective Date: Nov 07, 2017
Provider
QP85-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Pseudobulbar Affect (PBA)
Program effective Date: Oct 11, 2018